DepoMed may sell itself By: MarketMinute.com Stock News September 16, 2016 at 18:50 PM EDT Reuters reported that DepoMed Inc. (Nasdaq: DEPO) was working with Morgan Stanley to sell itself. Shares of the specialty pharmaceutical soared $3.10 to close at $24.34. Related Stocks: Depomed Inc